PSA – RMab

SKU: e7a4c70b3b1a Categories: , , ,

IHC of Prostate-Specifi c Antigen on an FFPE Prostatic Adenocarcinoma Tissue

IHC of Prostate-Specific Antigen on an FFPE Prostatic Adenocarcinoma Tissue

United States
Research Use
Safety Data Sheet


Control Slides
Intended Use For In Vitro Diagnostic Use
Summary and Explanation Prostate-specific antigen (PSA) is a protein produced by the cells of the prostate gland. PSA is present in small quantities in the serum of normal men, and is often elevated in the presence of prostate cancer and in other prostate disorders. Higher than normal levels of PSA are associated with both localized and metastatic prostate cancer.
The PSA antibody recognizes primary and metastatic prostatic neoplasms but not tumors of nonprostatic origin. The antigen is a 33-34 kDa glycoprotein that is restricted to cells of prostatic origin. An immunohistochemical study showed more than 95% of prostatic carcinomas stained with PSA. PSA is demonstrable in the cytoplasm of acinar and ductal cells of normal or malignant prostate tissue.
Antibody Type Rabbit Monoclonal Clone RBT-PSA
Isotype IgG Reactivity Paraffin, Frozen
Localization Cytoplasmic Control Prostate, Prostatic Adenocarcinoma
Presentation PSA is a rabbit monoclonal antibody derived from cell culture supernatant that is concentrated, dialyzed, filter sterilized and diluted in buffer pH 7.5, containing BSA and sodium azide as a preservative.
Catalog No. Antibody Type Dilution Volume/QTY
BSB 2140 Prediluted Ready-To-Use 3.0 ml
BSB 2141 Prediluted Ready-To-Use 7.0 ml
BSB 2142 Prediluted Ready-To-Use 15.0 ml
BSB 2143 Concentrated 1:250-1:1000 0.1 ml
BSB 2144 Concentrated 1:250-1:1000 0.5 ml
BSB 2145 Concentrated 1:250-1:1000 1.0 ml
BSB 2146 Control Slides 5
Note: For concentrated antibodies, please centrifuge prior to use to ensure recovery of all product.

Related products

Skip to content